000963 華東醫藥
按盤價 
38.980 +2.480 (+6.795%)
38.980 +2.480 (+6.795%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.893 | 14.328 | 14.217 | 14.754 | 20.940 |
| 總資產報酬率 ROA (%) | 7.217 | 8.775 | 8.590 | 8.991 | 12.350 |
| 投入資產回報率 ROIC (%) | 9.736 | 11.916 | 11.856 | 12.571 | 16.316 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.550 | 32.400 | 31.903 | 30.686 | 33.051 |
| 營業利潤率 (%) | 10.215 | 8.500 | 8.117 | 8.262 | 10.321 |
| 息稅前利潤/營業總收入 (%) | 10.077 | 8.658 | 8.245 | 8.245 | 10.354 |
| 淨利潤/營業總收入 (%) | 8.141 | 7.007 | 6.715 | 6.766 | 8.639 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.754 | 102.189 | 103.790 | 100.298 | 87.358 |
| 價值變動淨收益/利潤總額(%) | -2.767 | -6.736 | -3.731 | -3.406 | -0.797 |
| 營業外收支淨額/利潤總額(%) | -2.600 | 0.377 | -1.001 | -0.997 | -0.671 | 償債能力分析 |
| 流動比率 (X) | 1.483 | 1.712 | 1.730 | 1.671 | 1.698 |
| 速動比率 (X) | 1.141 | 1.315 | 1.288 | 1.242 | 1.226 |
| 資產負債率 (%) | 39.804 | 35.593 | 38.522 | 37.246 | 37.279 |
| 帶息債務/全部投入資本 (%) | 18.220 | 13.552 | 14.209 | 11.904 | -- |
| 股東權益/帶息債務 (%) | 438.416 | 620.086 | 578.494 | 712.153 | 663.497 |
| 股東權益/負債合計 (%) | 147.683 | 176.469 | 154.613 | 164.885 | 162.047 |
| 利息保障倍數 (X) | 83.432 | 68.709 | 39.733 | 129.087 | 101.974 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 74.689 | 64.930 | 65.048 | 65.453 | 0.000 |
| 存貨周轉天數 (天) | 58.477 | 57.587 | 59.364 | 60.424 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
